Hans Albrecht Bethe fue uno de los físicos más destacados del siglo XX, cuyo trabajo abarcó desde la física nuclear hasta la astrofísica, aportando descubrimientos cruciales que transformaron nuestra comprensión del universo. Su trayectoria profesional es si …
Hans Bethe: El científico que iluminó los secretos del Sol Read More »
Sufrir una luxación puede ser doloroso y desconcertante, especialmente si nos encontramos solos y no tenemos ayuda inmediata. La luxación es una lesión en la que un hueso se sale de su posición normal en una articulación, afectando comúnmente al hombro, codo …
¿Qué hacer cuando sufrimos una luxación y estamos solos? Read More »
Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and the FDA to ensure the devices work for everyone.
Medtronic settles pulse oximetry lawsuit alleging inaccuracies Read More »
Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.
Boston Scientific continues M&A run with Cortex buy Read More »
The payer joins several other insurers suing federal regulators over the 2025 quality ratings, which Elevance argues will cost it at least $375 million in bonus payments and rebates.
Elevance Health sues HHS over Medicare Advantage star ratings Read More »
Tarver is taking over as director of the Center for Devices and Radiological Health as the regulator grapples with questions around artificial intelligence in medical devices and racial bias in pulse oximeters.
In a deal worth up to $285 million initially for the lead program, Novo Nordisk will gain access to Ascendis’ TransCon technology platform in an effort to find novel GLP-1 candidates with reduced dosing frequency.
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis Read More »
¿Alguna vez te preguntaste por qué algunos apostadores parecen tener más éxito que otros? La respuesta está en los números. En la actualidad, las Apuestas deportivas con Betmaster y otros operadores han dejado de ser un simple juego de azar para co …
NeuroOne will get $3 million upfront for an exclusive license to distribute its radiofrequency ablation system designed to treat neurological disorders such as epilepsy and Parkinson’s disease.
Driven by the early approval of its updated COVID-19 vaccine, BioNTech far exceeded analysts’ expectations in the third quarter and reported its first quarterly profit in 2024. However, the German biotech also cut its outlook for the year.
BioNTech Handily Beats Q3 Expectations, Trims Full-Year Revenue Guidance Read More »
